Tüm Vücut Hipertermi (Whole Body Hyperthermia)
Özet
Modern tıpta yeni gelişmelerle birlikte onkoloji alanında bir çok farklı tedavi seçeneği oluşmuştur. Bu çeşitliliğe rağmen hastaların bir çoğunda progresyon ve tedavi direnci görülmektedir. Dolayısıyla bu direnci kırabilmek ve tedavi etkinliğini artırmak amacıyla farklı yöntemler uygulanmaktadır. Özellikle ateşin vücuttaki olumlu etkilerinden yola çıkılarak hipertermi tedavileri geliştirilmiştir. Tüm vücut hipertermi dirençli metastatik hastalıklarda farklı kanser türlerinde etkinliği farklı çalışmalar ile araştırılmış hipertermi tedavilerinden biridir. Bu bölümde tüm vücut hipertermi uygulamasının konvansiyonel tedavi yöntemlerine eklenmesi ile oluşan olumlu, olumsuz sonuçlar, yan etkiler, bilimsel kanıtlar eşliğinde sunulması planlanmıştır.
With new developments in modern medicine, many different treatment options have been developed in the field of oncology. Despite this diversity, most patients have resistance to treatment. Therefore, different methods are applied in order to break this resistance and increase the treatment effectiveness. In particular, hyperthermia treatments have been developed based on the positive effects of fever on the body. The effectiveness of whole body hyperthermia-resistant metastatic diseases in different types of cancer is one of the hyperthermia treatments that have been investigated with different studies. In this section, it is planned to present the positive, negative results, side effects, accompanied by scientific evidence that the application of whole body hyperthermia to conventional treatment methods.
Referanslar
Dobosz P, Dzieciątkowski T. The intriguing history of cancer immunotherapy. Front Immunol. 2019;10:2965.
Whole-body hyperthermia: a review of theory, design and application 2002;17(4):279-90.
The impact of whole-body hyperthermia interventions on mood and depression - are we ready for recommendations for clinical application? 2019;36(1):573-581.
Whole body hyperthermia treatment increases interleukin 10 and toll-like receptor 4 expression in patients with ankylosing spondylitis: a pilot study Int J Hyperthermia2014;30(6):393-401.
[Whole body hyperthermia in pain therapy. A controlled trial on patients with fibromyalgia] 2013 Feb;27(1):38-45
Mild Water-Filtered Infrared-A Whole-Body Hyperthermia Reduces Pain in Patients with Fibromyalgia Syndrome-A Randomized Sham-Controlled TrialJ Clin Med2023 Apr 18;12(8):2945.
Meffert H, Scherf HP, Meffert B. Milde Infrarot-A-Hyperthermie: Auswirkungen von Serienbestrahlungen mit wassergefilterter Infrarotstrahlung auf Gesunde und Kranke mit arterieller Hypertonie bzw. systemischer Sklerodermie. Akt Dermatol. 1993;19:142–8.
Winslow TB, Eranki A, Ullas S, et al. A pilot study of the effects of mild systemic heating onhuman head and neck tumour xenografts: analysis of tumour perfusion, interstitial fluid pressure,hypoxia and efficacy of radiation therapy. Int J Hyperthermia. 2015;31:693–701.
Evans SS, Repasky EA, Fisher DT. Fever and the thermal regulation of immunity: the immune system feels the heat. Nat Rev Immunol. 2015;15:335–49.
Heckel M. Beliebig langdauernde und gezielt dosierbare Erhöhung der Körpertemperatur durch eine Infrarotbestrahlungsanordnung. Strahlentherapie. 1960;111(1):149–53.
von Ardenne M. Principles and concept 1993 of the Systemic Cancer Multistep Therapy (sCMT). Extreme whole-body hyperthermia using the infrared-A technique IRATHERM 2000--selective thermosensitisation by hyperglycemia--circulatory back-up by adapted hyperoxemia. Strahlenther Onkol. 1994;170(10):581–9.
Schmidt KL. Hyperthermie und Fieber. Stuttgart: Hippokrates; 1987. p. 2.
Whole-Body Hyperthermia in Oncology: Renaissance in the Immunotherapy Era? Springer; 2022. Chapter 8
Proceedings: effects of hyperthermia in advanced malignancy 1973;60(11):905-6.
Whole-body hyperthermia. A systemic treatment for disseminated cancer 1977:(59):153-70.
Clinical effects of whole-body hyperthermia in adnanced malignancy 1974;21;4(5946):679-82.
Whole-body hyperthermia combined with chemotherapy and intensity-modulated radiotherapy for treatment of advanced nasopharyngeal carcinoma: a retrospective study with propensity score matching Int J Hyperthermia2021;38(1):1304-1312.
Fever range whole body hyperthermia for re-irradiation of head and neck squamous cell carcinomas: Final results of a prospective study Oral Oncol2021:116:105240.
Whole-body hyperthermia combined with hyperthermic intraperitoneal chemotherapy for the treatment of stage IV advanced gastric cancerInt J Hyperthermia2012;28(8):735-41.
Whole-body hyperthermia (41.8 degrees C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: a phase II study Ann Oncol2002;13(8):1197-204
Whole-body hyperthermia in the scope of von Ardenne's systemic cancer multistep therapy (sCMT) combined with chemotherapy in patients with metastatic colorectal cancer: a phase I/II study Int J Hyperthermia 2004 ;20(3):317-33.
Preclinical and clinical aspects of carboplatin and gemcitabine combined with whole-body hyperthermia for pancreatic adenocarcinoma Anticancer Res2009 Aug;29(8):3069-77.
A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer Eur J Cancer 2001 Jun;37(9):1111-7.
Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - a phase II study Gynecol Oncol. 2009 Feb;112(2):384-8.
Phase II study of carboplatin and whole body hyperthermia (WBH) in recurrent and metastatic cervical cancerGynecol Oncol2004;95(3):680-5.
Doxorubicin, cyclophosphamide, and whole body hyperthermia for treatment of advanced soft tissue sarcomaCancer1984 Jun 15;53(12):2585-91.
Chemotherapy resistant sarcoma treated with whole body hyperthermia (WBH) combined with 1-3-bis(2-chloroethyl)-1-nitrosourea (BCNU) Int J Hyperthermia. 1992;8(3):297-304.
Systemic hyperthermia and ICE chemotherapy for sarcoma patients: rationale and clinical statusAnticancer Res1997 Jul-Aug;17(4B):2899-902.
A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcomaOncology. 2003;64(4):312-21.
Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesotheliomaLung Cancer2003 Mar;39(3):339-45.
[Evaluation of the therapeutic benefit of 41.8 degrees C whole body hyperthermia plus ifosfamide, carboplatin and etoposide (ICE) for patients with malignant pleural mesothelioma using the Modified Brunner-Score (MBS)] Pneumologie2004;58(4):210-6.
Whole-body hyperthermia in combination with systemic therapy in advanced solid malignancies
